PHAT
Phathom Pharmaceuticals Inc
7.30$
+3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 51.6% | 22.3% | 18.8% | 14.4% | 12.9% | 13.1% | 12.8% | 12.5% | 13.3% | 20.6% | 20.3% | 17.1% | |
| – | 48.4% | 77.7% | 81.2% | 85.6% | 87.1% | 86.9% | 87.2% | 87.5% | 86.7% | 79.4% | 79.7% | 82.9% | |
| – | 1,963.8% | 493.2% | 100.7% | 53.2% | 28.9% | 32.2% | 23.0% | 14.2% | 13.0% | 13.3% | 10.5% | 12.6% | |
| – | 8,934.2% | 3,186.8% | 1,035.9% | 465.4% | 255.8% | 331.3% | 216.0% | 104.1% | 84.0% | 92.6% | 74.5% | 87.3% | |
| – | 10,293.8% | 3,736.4% | 1,136.6% | 518.5% | 287.4% | 363.5% | 238.9% | 118.3% | 97.0% | 106.0% | 85.0% | 99.9% | |
| – | -10,245.5% | -3,658.7% | -1,055.4% | -433.0% | -200.3% | -276.5% | -151.7% | -30.8% | -10.3% | -26.5% | -5.3% | -17.0% | |
| – | 1,910.4% | 897.9% | 242.5% | 113.0% | 62.7% | 63.4% | 44.3% | 32.5% | 28.5% | 27.1% | 20.3% | 26.5% | |
| – | -11,667.0% | -4,333.3% | -1,248.6% | -523.3% | -251.0% | -330.7% | -191.9% | -60.5% | -36.7% | -52.1% | -23.7% | -41.3% | |
| – | -2,454.3% | 8.9% | – | – | – | – | – | – | – | – | – | – | |
| – | -11,667.0% | -4,333.3% | -1,248.6% | -523.3% | -251.0% | -330.7% | -191.9% | -60.5% | -36.7% | -52.1% | -23.7% | -41.3% | |
| – | -9,729.6% | -3,424.2% | -1,003.3% | -409.1% | -187.7% | -266.7% | -147.1% | -27.7% | -8.0% | -24.8% | -3.2% | -14.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.